Blood marker study for colorectal cancer spread to belly
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks at how certain blood markers (nucleosome and CTCF) clear from the body in people with colorectal cancer that has spread to the lining of the belly. It also includes people with other conditions to compare. The goal is to learn more about these markers to help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You weigh at least 55 kg (about 121 pounds).
- You have either colorectal cancer (with or without spread to the lining of the belly), a non-cancer chronic inflammatory condition, or an abdominal infection like peritonitis or appendicitis.
- If you have colorectal cancer with spread to the belly lining, you must be a candidate for surgery to remove the tumors.
- If you have colorectal cancer with spread to the belly lining, the tumor must be mostly non-mucinous (less than 30% mucus-producing cells).
- You do not have any other active cancer (other than colorectal cancer) or a progressive autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people whose cancer has spread to the lining of the abdomen (the “belly lining”), including cancers from the digestive tract or ovaries. You may be asked to join because the study aims to learn how to better match care to different patterns of this belly lining cancer spread.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
This study looks at colorectal cancer that has spread to the peritoneum (the lining around the belly) using existing tumor tissue samples. It may help researchers better understand the cancer’s biology and improve future treatments.
This study looks at the way colorectal cancer appears when it spreads to the lining of the belly (peritoneum). It aims to see if certain patterns in the tissue can help doctors decide on the best treatment, such as whether to recommend surgery with heated chemotherapy. Taking part does not change your treatment—it just allows researchers to study your tissue samples.
This study looks for biological markers (clues in your body) to predict where colorectal cancer might come back or spread. It aims to help doctors personalize follow-up care and treatment decisions for each patient.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.